Anzeige
Mehr »
Mittwoch, 14.01.2026 - Börsentäglich über 12.000 News
Strategischer Schachzug: Germanium Mining sichert sich massives Flächenpotenzial im Kampf um die High-Tech-Vorherrschaft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14Z8X | ISIN: SE0007464862 | Ticker-Symbol: Q3I
Frankfurt
09.01.26 | 09:16
0,134 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ADDVISE GROUP AB Chart 1 Jahr
5-Tage-Chart
ADDVISE GROUP AB 5-Tage-Chart

Aktuelle News zur ADDVISE GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16:50ADDvise Group AB (publ): ADDvise announces financial update for 202550On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their...
► Artikel lesen
05.01.ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex113The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with...
► Artikel lesen
ADDVISE GROUP Aktie jetzt für 0€ handeln
02.01.ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex261ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in...
► Artikel lesen
30.12.25AMPLEX AB: Amplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDvise2
19.12.25ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise69On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares...
► Artikel lesen
19.12.25Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)1
19.12.25AMPLEX AB: Amplex increases the consideration in the cash offer to the shareholders and warrantholders of ADDvise and enters into agreements on conditional acquisitions of shares and warrants in ADDvise3
10.12.25ADDvise Group AB (publ) receives observation status299Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ). The rules of Nasdaq First North Growth Market state...
► Artikel lesen
10.12.25AMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)4
10.12.25Amplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)7
10.12.25ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex150Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price...
► Artikel lesen
12.11.25ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million145ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3...
► Artikel lesen
23.10.25ADDvise Group AB (publ): Interim report 2025, January 1-September 30136Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive....
► Artikel lesen
17.07.25ADDvise Group AB (publ): Interim report 2025, January 1-June 30166In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow...
► Artikel lesen
26.05.25ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year1.590ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will...
► Artikel lesen
12.05.25ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs166Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for...
► Artikel lesen
12.05.25ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025175ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved...
► Artikel lesen
09.05.25ADDvise Group AB (publ): Interim report 2025, January 1-March 31183In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating...
► Artikel lesen
24.04.25New equity right for trading, ADDvise Group AB251At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025. Security name: ADDvise Group AB TO 1 A Short...
► Artikel lesen
18.03.25XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025744Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1